A case of tetanus infection in an adult with a protective tetanus antibody level

被引:16
作者
Vollman, Kristan E. [1 ]
Acquisto, Nicole M. [2 ]
Bodkin, Ryan P. [3 ]
机构
[1] Univ Rochester, Med Ctr, Dept Pharm, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Pharm & Emergency Med, Rochester, NY 14642 USA
[3] Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14642 USA
关键词
CLINICAL TETANUS; ANTITETANUS;
D O I
10.1016/j.ajem.2013.10.025
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Tetanus is a bacterial infection caused by Clostridium tetani and most commonly presents as trismus or other muscle spasms. Despite the development of the tetanus toxoid vaccine, tetanus infection has not been eradicated. Additionally, while there are hypothesized protective levels of tetanus antibody, tetanus infection may still occur in properly vaccinated individuals. We report the case of a 31-year-old male that presented to the emergency department (ED) with a 2-day history of neck and jaw pain. He reports puncturing his hand with a rusty nail 10 days prior. His reported vaccination history was that he received his last booster vaccination 13 years prior to presentation. In the ED, tetanus vaccine, tetanus immune globulin, and metronidazole were administered. His symptoms improved over the next 2 days and resolved at day 6. Despite his presentation of tetanus infection and rule out of other causes for his symptoms, his tetanus antibody level was reported at 8.4 U/ mL, which is considered to be protective. A tetanus antibody level that is adequate for protective immunity should not preclude a patient from treatment of tetanus infection. This case demonstrates that a thorough history, physical exam, and rule out of other causes should guide treatment when there is concern for a tetanus infection.
引用
收藏
页码:392.e3 / 392.e4
页数:2
相关论文
共 19 条
[1]   Fatal tetanus in a drug abuser with "protective" antitetanus antibodies [J].
Abrahamian, FM ;
Pollack, CV ;
LoVecchio, F ;
Nanda, R ;
Carlson, RW .
JOURNAL OF EMERGENCY MEDICINE, 2000, 18 (02) :189-193
[2]  
Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P13
[3]  
[Anonymous], 2012, HYPERTET PACK INS
[4]   Tetanus in a fully immunized child [J].
Atabek, ME ;
Pirgon, O .
JOURNAL OF EMERGENCY MEDICINE, 2005, 29 (03) :345-346
[5]   A case of clinical tetanus in a patient with protective antitetanus antibody level [J].
Beltran, Alvaro ;
Go, Eddie ;
Haq, Mahenaaz ;
Clarke, Hillary B. ;
Zaman, Muhammad ;
Recco, Rose A. .
SOUTHERN MEDICAL JOURNAL, 2007, 100 (01) :83-83
[6]   TETANUS DESPITE PREEXISTING ANTI-TETANUS ANTIBODY [J].
BERGER, SA ;
CHERUBIN, CE ;
NELSON, S ;
LEVINE, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (08) :769-770
[7]   SEROLOGIC THERAPY OF TETANUS IN UNITED-STATES, 1965-1971 [J].
BLAKE, PA ;
FELDMAN, RA ;
BUCHANAN, TM ;
BROOKS, GF ;
BENNETT, JV .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (01) :42-44
[8]  
Bleck Thomas P., 1997, P629
[9]   SEVERE TETANUS IN IMMUNIZED PATIENTS WITH HIGH ANTITETANUS TITERS [J].
CRONE, NE ;
REDER, AT .
NEUROLOGY, 1992, 42 (04) :761-764
[10]   Tetanus in a renal transplant recipient exhibiting the presence of circulating antitetanus antibodies determined by ELISA [J].
de la Chapelle, A ;
Lavabre, O ;
Pinsard, M ;
Delamonica, J ;
Relyveld, EH .
BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (04) :208-210